Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR01198
|
|||||
Drug Name |
Gentamicin
|
|||||
Synonyms |
(1R,2S,3S,4R,6S)-4,6-diamino-3-[3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyloxy]-2-hydroxycyclohexyl 2-amino-2,3,4,6,7-pentadeoxy-6-(methylamino)-beta-L-lyxo-heptopyranoside; (1R,2S,3S,4R,6S)-4,6-diamino-3-{[3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyl]oxy}-2-hydroxycyclohexyl (6x)-2-amino-2,3,4,6,7-pentadeoxy-6-(methylamino)-alpha-D-erythro-heptopyranoside; (2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,6S)-3-amino-6-[1-(methylamino)ethyl]oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol; 2-[4,6-diamino-3-[3-amino-6-[1-(methylamino)ethyl]oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol; 4,6-diamino-3-{[3-deoxy-4-c-methyl-3-(methylamino)pentopyranosyl]oxy}-2-hydroxycyclohexyl 2-amino-2,3,4,6,7-pentadeoxy-6-(methylamino)heptopyranoside; Alcomicin; Apogen; Bristagen; Cidomycin; G-Mycin; G-Myticin; GENTAMYCIN; Garamycin; Garamycin (TN); Garamycin Otic Solution; Garasol; Genoptic Liquifilm; Genoptic S.O.P.; Gentacidin; Gentacycol; Gentafair; Gentak; Gentamar; Gentamcin Sulfate; Gentamicin (BAN); Gentamicin (TN); Gentamicin C1; Gentamicin sulphate sterile; Gentamicina; Gentamicina [INN-Spanish]; Gentamicine; Gentamicine [INN-French]; Gentamicins; Gentamicinum; Gentamicinum [INN-Latin];Gentamycin-creme; Gentamycin-creme [German]; Gentamycinum; Gentavet; Gentocin; Jenamicin; O-2-amino-2,3,4,6,7-pentadeoxy-6-(methylamino)-alpha-D-ribo-heptopyranosyl-(1-4)-O-(3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyl-(1-6))-2-deoxy-D-streptamine; Ocu-Mycin; Refobacin; Refobacin TM; Spectro-Genta; U-Gencin; Uromycine
|
|||||
Drug Type |
Small molecular drug
|
|||||
Therapeutic Class |
Antibiotics
|
|||||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C21H43N5O7
|
|||||
Canonical SMILES |
CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
|
|||||
InChI |
InChI=1S/C21H43N5O7/c1-9(25-3)13-6-5-10(22)19(31-13)32-16-11(23)7-12(24)17(14(16)27)33-20-15(28)18(26-4)21(2,29)8-30-20/h9-20,25-29H,5-8,22-24H2,1-4H3
|
|||||
InChIKey |
CEAZRRDELHUEMR-UHFFFAOYSA-N
|
|||||
CAS Number |
CAS 1403-66-3
|
|||||
Pharmaceutical Properties | Molecular Weight | 477.6 | Topological Polar Surface Area | 200 | ||
Heavy Atom Count | 33 | Rotatable Bond Count | 7 | |||
Hydrogen Bond Donor Count | 8 | Hydrogen Bond Acceptor Count | 12 | |||
XLogP |
-4.1
|
|||||
PubChem CID | ||||||
PubChem SID |
103135455
, 104303599
, 117535962
, 124766025
, 126407615
, 126625531
, 126661266
, 126691181
, 127340104
, 127340105
, 127340106
, 134337440
, 134980500
, 135650301
, 137239444
, 142147875
, 152100630
, 160964140
, 196105377
, 223658860
, 226847630
, 242084438
, 246167234
, 250134950
, 29222600
, 46506523
, 4652583
, 49972189
, 53787495
, 57321817
, 74460187
, 8152203
, 92712501
, 96024706
|
|||||
ChEBI ID |
ChEBI:17833
|
|||||
TTD Drug ID |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.